This article needs to be updated.(January 2023) |
Date | 17 February 2021 | – 13 April 2023
---|---|
Location | Japan |
Cause | COVID-19 pandemic in Japan |
Target | Full immunisation of people in Japan against COVID-19 |
Organised by | Ministry of Health, Labour and Welfare |
Participants | 77,098,247 people have received at least one vaccine dose (7 September 2021) 61,995,078 have been fully vaccinated (received both vaccine doses, 7 September 2021)[2][3] |
Outcome | 81.8% of the Japanese population has received their first dose of a two-dose vaccine 80.6% has been fully vaccinated 58.8% has received a booster shot |
Website | Ministry of Health, Labour and Welfare |
COVID-19 vaccination in Japan started later than in most other major economies.[4] The country has frequently been regarded as "slow" in its vaccination efforts.[5][6]
Japan has so far approved Pfizer–BioNTech, Moderna and Oxford–AstraZeneca for use. In April 2024, data from the government shows that 79.5% of people have had their second dose, while 80.4% have received first shot.[7] Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third (booster) dose.[8]